Career Development Program

职业发展计划

基本信息

  • 批准号:
    9546619
  • 负责人:
  • 金额:
    $ 10.7万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-09-01 至 2019-08-31
  • 项目状态:
    已结题

项目摘要

The Career Development Program (CDP) is a critical and integral component of the Duke SPORE in Brain Cancer that facilitates the identification, support, and mentoring of promising new and early-stage investigators in translational neuro-oncology. Projects will be encouraged to be broadly collaborative and to test novel paradigms that will further expand the scope of the brain tumor diagnosis, prevention, and management. The DRP will specifically target projects having a strong likelihood of becoming successful and independent research projects or having a high potential of developing into full SPORE projects that replace projects within the SPORE that are not progressing satisfactorily. The Specific Aims of the CDP are to: 1) Identify and support meritorious translational projects led by NIH-designated new or early stage investigators that have a high probability of impacting the diagnosis, treatment or prevention of brain tumors; 2) Recruit and retain promising women and minority new and early-stage investigators with a career focus in translational neuro-oncology research; 3) Facilitate access to programs for leadership training and a highly successful program for grant writing that includes mentoring of early-stage and new investigators to enable such faculty members to achieve independent faculty status with emphasis on neuro-oncology research; and 4) Provide continuing evaluation of progress on funded projects and facilitate their evolution into full SPORE projects or independently funded projects. This application builds upon the highly successful CDP of the previous Duke Brain Cancer SPORE that resulted in the successful development of several early-stage scientists, including a number of women and minority investigators. This application builds upon and extends this success through the integration of the SPORE CDP with a highly advanced faculty development program, which offers a wide range of short courses to enable young faculty to learn skills related to leadership, scientific writing, personnel management, grants management and others. This integration of the CDP with the Office of Faculty Development will ensure longitudinal mentorship and development of CDP award recipients throughout their tenure at our medical center. We anticipate the successful recruitment of outstanding new talent to the field of neuro-oncology research, as we have done in the past, through this highly visible awards program.
职业发展计划(CDP)是杜克SPORE的重要组成部分, 脑癌,有利于识别,支持和指导有前途的新的和早期阶段 转化神经肿瘤学的研究者。将鼓励项目广泛合作, 测试新的范例,将进一步扩大脑肿瘤诊断,预防和治疗的范围。 管理DRP将专门针对有很大成功可能性的项目, 独立的研究项目或具有发展成为完整的SPORE项目的高潜力, 在项目中,没有取得令人满意的进展。发展政策委员会的具体目标是: 1)识别和支持由NIH指定的新的或早期阶段领导的有价值的翻译项目 有很大可能影响诊断、治疗或预防的研究者 脑肿瘤; 2)招募和留住有前途的女性和少数族裔新的和早期的调查人员,并提供 专注于转化神经肿瘤学研究; 3)促进获得领导力培训计划和一个非常成功的赠款计划 写作,包括指导早期阶段和新的调查人员,使这样的教师 成员实现独立的教师地位,重点是神经肿瘤学研究; 4)持续评估受资助项目的进展情况,并促进其发展成为 完全的SPORE项目或独立资助的项目。 该应用程序建立在之前杜克脑癌孢子的高度成功的CDP基础上, 成功培养了几位早期科学家,其中包括一些女性, 少数民族调查员此应用程序构建在此成功的基础上,并通过集成 SPORE CDP拥有高度先进的教师发展计划,提供广泛的短期课程 使年轻的教师能够学习与领导力,科学写作,人事管理,赠款 管理及其他。CDP与教师发展办公室的整合将确保 CDP奖获得者在我们的医疗机构任职期间的纵向指导和发展 中心我们期待在神经肿瘤学领域成功招募优秀的新人才 正如我们过去所做的那样,通过这个高度可见的奖项计划进行研究。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David M. Ashley其他文献

Phase II study of carboplatin (CBDCA) in progressive low-grade gliomas.
卡铂 (CBDCA) 在进行性低级别胶质瘤中的 II 期研究。
  • DOI:
  • 发表时间:
    1998
  • 期刊:
  • 影响因子:
    4.1
  • 作者:
    Albert Moghrabi;Henry S Friedman;David M. Ashley;K. Bottom;T. Kerby;Elizabeth A. Stewart;Carol S. Bruggers;James M. Provenzale;Martin A. Champagne;Linda Hershon;M. Watral;Janis Ryan;Karima Rasheed;Shelley Lovell;David N. Korones;Herbert E. Fuchs;Timothy M George;R. McLendon;A. Friedman;Edward G. Buckley;D. Longee
  • 通讯作者:
    D. Longee
Brain immunology and immunotherapy in brain tumours
脑肿瘤中的脑免疫学与免疫疗法
  • DOI:
    10.1038/s41568-019-0224-7
  • 发表时间:
    2019-12-05
  • 期刊:
  • 影响因子:
    66.800
  • 作者:
    John H. Sampson;Michael D. Gunn;Peter E. Fecci;David M. Ashley
  • 通讯作者:
    David M. Ashley
A peptide vaccine targeting the CMV antigen pp65 in children and young adults with recurrent high-grade glioma and medulloblastoma: a phase 1 trial
针对患有复发性高级别胶质瘤和髓母细胞瘤的儿童和青少年的针对巨细胞病毒抗原 pp65 的肽疫苗:一项 1 期试验
  • DOI:
    10.1038/s43018-025-00998-z
  • 发表时间:
    2025-06-12
  • 期刊:
  • 影响因子:
    28.500
  • 作者:
    Eric M. Thompson;David M. Ashley;Katayoun Ayasoufi;Pamela Norberg;Gerald Archer;Evan D. Buckley;James E. Herndon;Ashley Walter;Bridget Archambault;Charlene Flahiff;Denise Jaggers;Laura Gorski;Luis A. Sanchez;Kendra Congdon;Kelly Hotchkiss;Sarah L. Cook;Eliese Moelker;Gordana Vlahovic;Elizabeth Reap;Kristin Schroeder;Dina Randazzo;Annick Desjardins;Margaret O. Johnson;Katherine Peters;Mustafa Khasraw;Henry Friedman;Duane A. Mitchell;John H. Sampson;Daniel Landi
  • 通讯作者:
    Daniel Landi
The evolution of the histology in pleomorphic xanthoastrocytomas in children: a study of 15 cases
儿童多形性黄色星形细胞瘤15例组织学演变
  • DOI:
    10.1097/pat.0b013e328340bb98
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    4.5
  • 作者:
    Xiangru Wu;P. Bandopadhayay;J. Ng;David M. Ashley;C. Chow
  • 通讯作者:
    C. Chow
Evolocumab as an immunomodulator in glioma: A window of opportunity trial evaluating PCSK9 inhibition to enhance surface MHC-I on tumor
Evolocumab 作为神经胶质瘤的免疫调节剂:评估 PCSK9 抑制以增强肿瘤表面 MHC-I 的机会之窗试验
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kirit Singh;Matthew W. Foster;Marlene J. Violette;K. Hotchkiss;C. Railton;E. Blandford;Kathryn E. Blethen;Elizabeth L. Thomas;David M. Ashley;A. Desjardins;Henry Friedman;Margaret O. Johnson;Allan Friedman;Stephen T Keir;E. Buckley;James Herndon;R. McLendon;John H. Sampson;Evan Calabrese;Giselle Y. Lopez;Gerald A. Grant;Anoop P. Patel;Chuan;P. Fecci;M. Khasraw;The Preston
  • 通讯作者:
    The Preston

David M. Ashley的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David M. Ashley', 18)}}的其他基金

ATRX mutations, innate immune activation and therapeutic vulnerability in malignant gliomas
ATRX 突变、先天免疫激活和恶性胶质瘤的治疗脆弱性
  • 批准号:
    10375084
  • 财政年份:
    2022
  • 资助金额:
    $ 10.7万
  • 项目类别:
ATRX mutations, innate immune activation and therapeutic vulnerability in malignant gliomas
ATRX 突变、先天免疫激活和恶性胶质瘤的治疗脆弱性
  • 批准号:
    10666347
  • 财政年份:
    2022
  • 资助金额:
    $ 10.7万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10488238
  • 财政年份:
    2021
  • 资助金额:
    $ 10.7万
  • 项目类别:
6-thio-2'-deoxyguanosine in GBM: Pre-clinical Evaluation of Mechanism of action, Efficacy and Biomarker identification
GBM 中的 6-硫代-2-脱氧鸟苷:作用机制、功效和生物标志物鉴定的临床前评估
  • 批准号:
    10488242
  • 财政年份:
    2021
  • 资助金额:
    $ 10.7万
  • 项目类别:
6-thio-2'-deoxyguanosine: A Novel Immunogenic Telomerase-Mediated Therapy in Glioblastoma - A Duke and UTSW Collaboration
6-硫代-2-脱氧鸟苷:一种新型免疫原性端粒酶介导的胶质母细胞瘤疗法 - 杜克大学和 UTSW 合作
  • 批准号:
    10488237
  • 财政年份:
    2021
  • 资助金额:
    $ 10.7万
  • 项目类别:
6-thio-2'-deoxyguanosine: A Novel Immunogenic Telomerase-Mediated Therapy in Glioblastoma - A Duke and UTSW Collaboration
6-硫代-2-脱氧鸟苷:一种新型免疫原性端粒酶介导的胶质母细胞瘤疗法 - 杜克大学和 UTSW 合作
  • 批准号:
    10305565
  • 财政年份:
    2021
  • 资助金额:
    $ 10.7万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10305566
  • 财政年份:
    2021
  • 资助金额:
    $ 10.7万
  • 项目类别:
6-thio-2'-deoxyguanosine in GBM: Pre-clinical Evaluation of Mechanism of action, Efficacy and Biomarker identification
GBM 中的 6-硫代-2-脱氧鸟苷:作用机制、功效和生物标志物鉴定的临床前评估
  • 批准号:
    10305568
  • 财政年份:
    2021
  • 资助金额:
    $ 10.7万
  • 项目类别:
Is Low Tumor Mutational Burden Predictive of Response to Oncolytic Polio Virus Therapy in Recurrent Glioblastoma?
低肿瘤突变负荷是否可以预测复发性胶质母细胞瘤对溶瘤脊髓灰质炎病毒治疗的反应?
  • 批准号:
    9807277
  • 财政年份:
    2019
  • 资助金额:
    $ 10.7万
  • 项目类别:
Experimental Therapy for Brain Tumors
脑肿瘤的实验治疗
  • 批准号:
    10005980
  • 财政年份:
    2018
  • 资助金额:
    $ 10.7万
  • 项目类别:

相似海外基金

Broadening Participation Research: Understanding faculty attitudes, competency, and perceptions of providing career advising to African American STEM students at HBCUs
扩大参与研究:了解教师对 HBCU 的非裔美国 STEM 学生提供职业建议的态度、能力和看法
  • 批准号:
    2306671
  • 财政年份:
    2023
  • 资助金额:
    $ 10.7万
  • 项目类别:
    Continuing Grant
Cognitive Behavioral Faith-based Depression Intervention For African American Adults (CB-FAITH): An Effectiveness And Implementation Trial
非裔美国成年人基于认知行为信仰的抑郁干预 (CB-FAITH):有效性和实施试验
  • 批准号:
    10714464
  • 财政年份:
    2023
  • 资助金额:
    $ 10.7万
  • 项目类别:
DELINEATING THE ROLE OF THE HOMOCYSTEINE-FOLATE-THYMIDYLATE SYNTHASE AXIS AND URACIL ACCUMULATION IN AFRICAN AMERICAN PROSTATE TUMORS
描述同型半胱氨酸-叶酸-胸苷酸合成酶轴和尿嘧啶积累在非裔美国人前列腺肿瘤中的作用
  • 批准号:
    10723833
  • 财政年份:
    2023
  • 资助金额:
    $ 10.7万
  • 项目类别:
Preventing Firearm Suicide Deaths Among Black/African American Adults
防止黑人/非裔美国成年人因枪支自杀死亡
  • 批准号:
    10811498
  • 财政年份:
    2023
  • 资助金额:
    $ 10.7万
  • 项目类别:
Exploring PTSD Symptoms, Barriers and Facilitators to Mindfulness-based Stress Reduction for Justice-Involved Black/African American Female Adolescents and Parents/Caregivers
探索创伤后应激障碍 (PTSD) 症状、障碍和促进因素,为涉及正义的黑人/非裔美国女性青少年和父母/照顾者进行基于正念的减压
  • 批准号:
    10593806
  • 财政年份:
    2023
  • 资助金额:
    $ 10.7万
  • 项目类别:
BCSER - PVEST: A Dynamic Framework for Investigating STEM Interest, Attitude and Identity Among African American Middle School Students
BCSER - PVEST:调查非裔美国中学生 STEM 兴趣、态度和身份的动态框架
  • 批准号:
    2327055
  • 财政年份:
    2023
  • 资助金额:
    $ 10.7万
  • 项目类别:
    Standard Grant
Making the Connection: Understanding the dynamic social connections impacting type 2 diabetes management among Black/African American men
建立联系:了解影响黑人/非裔美国男性 2 型糖尿病管理的动态社会联系
  • 批准号:
    10782674
  • 财政年份:
    2023
  • 资助金额:
    $ 10.7万
  • 项目类别:
Building a Community-Based Mental Health Literacy Intervention for African American Young Adults
为非裔美国年轻人建立基于社区的心理健康素养干预措施
  • 批准号:
    10738855
  • 财政年份:
    2023
  • 资助金额:
    $ 10.7万
  • 项目类别:
African American Literature in "post" Post-Racial America
“后”后种族美国中的非裔美国文学
  • 批准号:
    23K00376
  • 财政年份:
    2023
  • 资助金额:
    $ 10.7万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Neurovascular Control of Renal Blood Flow During Exercise in African American Adults
非裔美国成年人运动期间肾血流的神经血管控制
  • 批准号:
    10653381
  • 财政年份:
    2023
  • 资助金额:
    $ 10.7万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了